Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-11

Clinical Trial Update: Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic Fibrosis

View source ↗

Summary

A completed study assessed whether ultrasound can predict the risk of hepatic cirrhosis in cystic fibrosis patients with pancreatic insufficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Cystic Fibrosis, Pancreatic Insufficiency | Status: COMPLETED